未登录

S

Shijie Shang

University of Jinan

H指数:6

被引数:181

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A new perspective on radiotherapy in the comprehensive treatment of cancer

癌症综合治疗中放射治疗的新视角

Precision Radiation Oncology

IF2.1

2026-05-010

OAAI

Targeting gut microbiota and metabolites in cancer radiotherapy

靶向肠道微生物群及其代谢物在癌症放射治疗中的应用

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2025-09-300

OAAI

Gut Escherichia coli promotes lung cancer by increasing circulating STAMBP production

肠道大肠杆菌通过增加循环STAMBP的产生来促进肺癌

DISCOVER ONCOLOGY

IF2.9

2025-04-030

OA

The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2024-08-260

OAAI

Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis

肺癌发展和免疫治疗中的肠道微生物代谢产物: 对肠-肺轴的新见解

IF10.1

2024-08-013

PRE

The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Patients With Non-Small Cell Lung Cancer Receiving Lung Radiation Therapy and Immunotherapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2024-05-012

PRE

High HPK1+PD-1+TIM-3+CD8+T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-01-014

PRE

Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

未切除的III期NSCLC患者的治疗模式: 监测、流行病学和最终结果 (SEER) 数据库分析

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-176

OAAI

Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates

放疗联合免疫治疗非小细胞肺癌的挑战与进展

CANCER COMMUNICATIONS

IF24.9

2021-10-1746

OAAI